GPR142 is an islet-enriched G protein-coupled receptor that has been investigated as a novel therapeutic target for the treatment of type 2 diabetes by virtue of its insulin secretagogue activity. The gene discussed is GPR142; the disease is type 2 diabetes mellitus.